Introducing the results related to the programs that AMED's supports R&D
Achievements
What's New
-
2021.12.23CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC,identified using LC-SCRUM-Asia genomic screening platform - A step further to precision medicine -
-
2021.12.16B-cell signaling factors essential for immunological memory in infections and vaccines discovered
-
2021.11.12Study shows efficacy of dual-HER2 targeted therapy for patients with HER2-positive colorectal cancer - Investigator-initiated trial based on GI-SCREEN-Japan/GOZILA study may lead to the world's first effective treatment for HER2-positive colorectal cancer -
-
2021.5.20New SATREPS Projects for FY 2021 under AMED International Collaborative Research Program
-
2021.3.4First wearable device can monitor jaundice-causing bilirubin and vitals in newborns
-
2021.2.3Development of a method for producing conjunctival epithelium from iPS cells - Novel technology to accelerate drug discovery and regenerative medicine for eye diseases -
-
2021.2.3Small-molecule anti-HIV active compounds targeting HIV-1 capsid protein - Development of novel therapeutic agents for drug-resistant viruses -
-
2021.1.29Health tips in the mouth - First large-scale oral microbiome analysis in Japan -
-
2021.1.29Development of the world's first quantum sensors to detect “oxidative stress” - Preemptive medicine for preventing lifestyle-related diseases and inflammation using optical imaging and MRI -
-
2021.1.27Development of a culture medium for convenient and efficient proliferation of human iPS cells - Cost reduction in regenerative medicine -